ClinicalTrials.Veeva

Find clinical trials for Multiple Myeloma in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Leukemia
Cancer
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Aurora, CO, USA:

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

lenalidomide, and dexamethasone (DRd) for first-line treatment of multiple myeloma (MM).FDA has approved selinexor plus dexamethaso ...

Enrolling
Plasma Cell Myeloma
Myeloma, Plasma Cell
Drug: Selinexor
Drug: Daratumumab

Phase 2

US Oncology Network
US Oncology Network

Denver, Colorado, United States and 9 other locations

of three drugs called lenalidomide, subcutaneous (injection under the skin) bortezomib, and dexamethasone (RVD) as a possible treatment for multiple...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Procedure: Stem Cell Mobilization

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Denver, Colorado, United States and 7 other locations

This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...

Active, not recruiting
Smoldering Multiple Myeloma
Monoclonal Gammopathy
Drug: Daratumumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Denver, Colorado, United States and 5 other locations

This is a first in human, phase 1, multicenter, open-label study to determine the safety and tolerability of IGM-2644 as a single agent in participan...

Enrolling
Multiple Myeloma
Drug: IGM-2644

Phase 1

IGM Biosciences

Denver, Colorado, United States and 4 other locations

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: CC-92480

Phase 1, Phase 2

Celgene
Celgene

Denver, Colorado, United States and 49 other locations

This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients...

Enrolling
Multiple Myeloma
Drug: Teclistamab
Drug: Tocilizumab

Phase 2

Sarah Cannon Research Institute
Sarah Cannon Research Institute

Denver, Colorado, United States and 3 other locations

This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...

Enrolling
Multiple Myeloma
Myeloma
Drug: Bendamustine
Drug: FT576 (Allogenic CAR NK cells with BCMA expression)

Phase 1

Fate Therapeutics
Fate Therapeutics

Denver, Colorado, United States and 13 other locations

The purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple...

Active, not recruiting
Multiple Myeloma
Drug: Fludarabine
Drug: Bendamustine

Phase 1

Juno Therapeutics

Denver, Colorado, United States and 9 other locations

of these combinations in participants with relapsed or refractory multiple myeloma. The study will consist of 3 distinct parts: Par ...

Active, not recruiting
Multiple Myeloma
Drug: Bortezomib
Drug: Daratumumab

Phase 2

AbbVie
AbbVie

Aurora, Colorado, United States and 39 other locations

The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...

Active, not recruiting
Multiple Myeloma
Biological: Ixazomib
Drug: Dexamethasone

Phase 2

The Washington University
The Washington University

Denver, Colorado, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems